You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

MICRONASE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Micronase patents expire, and when can generic versions of Micronase launch?

Micronase is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in MICRONASE is glyburide. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the glyburide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Micronase

A generic version of MICRONASE was approved as glyburide by TEVA on August 29th, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MICRONASE?
  • What are the global sales for MICRONASE?
  • What is Average Wholesale Price for MICRONASE?
Summary for MICRONASE
Drug patent expirations by year for MICRONASE
Recent Clinical Trials for MICRONASE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Texas Tech University Health Sciences Center, El PasoEarly Phase 1
University of MarylandPhase 1
Washington University School of MedicinePhase 1

See all MICRONASE clinical trials

US Patents and Regulatory Information for MICRONASE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer MICRONASE glyburide TABLET;ORAL 017498-001 May 1, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer MICRONASE glyburide TABLET;ORAL 017498-002 May 1, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer MICRONASE glyburide TABLET;ORAL 017498-003 May 1, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MICRONASE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer MICRONASE glyburide TABLET;ORAL 017498-003 May 1, 1984 ⤷  Sign Up ⤷  Sign Up
Pfizer MICRONASE glyburide TABLET;ORAL 017498-001 May 1, 1984 ⤷  Sign Up ⤷  Sign Up
Pfizer MICRONASE glyburide TABLET;ORAL 017498-002 May 1, 1984 ⤷  Sign Up ⤷  Sign Up
Pfizer MICRONASE glyburide TABLET;ORAL 017498-003 May 1, 1984 ⤷  Sign Up ⤷  Sign Up
Pfizer MICRONASE glyburide TABLET;ORAL 017498-001 May 1, 1984 ⤷  Sign Up ⤷  Sign Up
Pfizer MICRONASE glyburide TABLET;ORAL 017498-003 May 1, 1984 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.